Cytokinetics share price today

(CYTK)

Cytokinetics share price is $48.53 & ₹4,132.77 as on 25 Dec 2024, 2.30 'hrs' IST

$48.53

▲

-0.42

(-0.86%)

Market is closed - opens 8 PM, 26 Dec 2024

View live Cytokinetics share price in Dollar and Rupees. Guide to invest in Cytokinetics from India. Also see the sentimental analysis on Indian investors investing in Cytokinetics. Get details on the Indian mutual funds that are investing in Cytokinetics. Get Analyst recommendations and forecasts along with all the Cytokinetics's financials.

Cytokinetics share price movements

Today's Low: $48.07
Today's High: $49.03
$48.53
0.95%
Downside
Day's Volatility :1.96%
Upside
1.02%
52 Weeks Low: $43.53
52 Weeks High: $110.25
$48.53
10.31%
Downside
52 Weeks Volatility :60.52%
Upside
55.98%

Cytokinetics Returns

Period	Cytokinetics Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-7.08%	-10.0%	0.0%
6 Months	-5.41%	-5.7%	0.0%
1 Year	7.09%	2.8%	0.0%
3 Years	6.76%	-0.4%	-21.1%

Cytokinetics Key Statistics

in dollars & INR

Previous Close	$48.95
Open	$48.85
Today's High	$49.03
Today's Low	$48.07
Market Capitalization	$5.8B
Today's Volume	$1.0M
52 Week High	$110.25
52 Week Low	$43.5251
Revenue TTM	$3.2M
EBITDA	$-511.1M
Earnings Per Share (EPS)	$-5.38
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-572.15%

How to invest in Cytokinetics from India?

It is very easy for Indian residents to invest directly in Cytokinetics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Cytokinetics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Cytokinetics or CYTK on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Cytokinetics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Cytokinetics shares which would translate to 0.018 fractional shares of Cytokinetics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Cytokinetics, in just a few clicks!

Returns in Cytokinetics for Indian investors in Rupees

Investment Value

₹1,00,000

Cytokinetics investment value today

Current value as on today

₹1,08,568

Returns

₹8,568

(+8.57%)

Returns from Cytokinetics Stock

₹6,169 (+6.17%)

Dollar Returns

₹2,399 (+2.4%)

Indian investors sentiment towards Cytokinetics

47%

Period: Sep 25, 2024 to Dec 24, 2024. Change in 30 Days versus previous period

Search volume for Cytokinetics on INDmoney from India has grown in the last 30 days as on Dec 25, 2024. 47% more investors are searching Cytokinetics in the last 30 days versus the previous period.

Global Institutional Holdings in Cytokinetics

BlackRock Inc
12.43%
FMR Inc
10.25%
Vanguard Group Inc
9.97%
T. Rowe Price Investment Management,Inc.
8.21%
Wellington Management Company LLP
6.59%
State Street Corp
5.47%

Analyst Recommendation on Cytokinetics

Buy

84%Buy

16%Hold

0%Sell

Based on 25 Wall street analysts offering stock ratings for Cytokinetics(by analysts ranked 0 to 5 stars)

Based on 25 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Cytokinetics

What analysts predicted

Upside of 66.26%

Current:

$48.53

Target:

$80.69

Insights on Cytokinetics

Price Movement
In the last 7 days, CYTK stock has moved up by 2.4%
Increasing Revenue
Revenue is up for the last 2 quarters, 249.0K → 463.0K (in $), with an average increase of 46.2% per quarter
Decreasing Net Profit
Netprofit is down for the last 3 quarters, -135.64M → -160.54M (in $), with an average decrease of 8.8% per quarter
CYTK vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 26.8% return, outperforming this stock by 17.0%
CYTK vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 24.7% return, outperforming this stock by 15.1%
Price to Sales
ForCYTK every $1 of sales, investors are willing to pay $1631.7, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.7 for every $1 of sales.

Cytokinetics Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$31.5M	↑ 135.64%
Net Income	$-106.3M	↓ 16.83%
Net Profit Margin	-337.41%	↑ 618.53%

	FY19	Y/Y Change
Revenue	$26.9M	↓ 14.71%
Net Income	$-149.1M	↑ 40.23%
Net Profit Margin	-554.76%	↓ 217.35%

	FY20	Y/Y Change
Revenue	$55.8M	↑ 107.79%
Net Income	$-164.1M	↑ 10.12%
Net Profit Margin	-294.0%	↑ 260.76%

	FY21	Y/Y Change
Revenue	$70.4M	↑ 26.15%
Net Income	$-242.4M	↑ 47.67%
Net Profit Margin	-344.14%	↓ 50.14%

	FY22	Y/Y Change
Revenue	$94.6M	↑ 34.3%
Net Income	$-402.6M	↑ 66.09%
Net Profit Margin	-425.58%	↓ 81.44%

	FY23	Y/Y Change
Revenue	$7.5M	↓ 92.04%
Net Income	$-526.2M	↑ 30.73%
Net Profit Margin	-7.0K%	↓ 6563.05%

	Q2 FY23	Q/Q Change
Revenue	$867.0K	↓ 81.21%
Net Income	$-128.6M	↓ 0.62%
Net Profit Margin	-14.8K%	↓ 12031.02%

	Q3 FY23	Q/Q Change
Revenue	$378.0K	↓ 56.4%
Net Income	$-129.4M	↑ 0.61%
Net Profit Margin	-34.2K%	↓ 19401.6%

	Q4 FY23	Q/Q Change
Revenue	$1.7M	↑ 342.33%
Net Income	$-136.9M	↑ 5.77%
Net Profit Margin	-8.2K%	↑ 26051.06%

	Q1 FY24	Q/Q Change
Revenue	$835.0K	↓ 50.06%
Net Income	$-135.6M	↓ 0.92%
Net Profit Margin	-16.2K%	↓ 8057.11%

	Q2 FY24	Q/Q Change
Revenue	$249.0K	↓ 70.18%
Net Income	$-143.3M	↑ 5.66%
Net Profit Margin	-57.6K%	↓ 41312.76%

	Q3 FY24	Q/Q Change
Revenue	$463.0K	↑ 85.94%
Net Income	$-160.5M	↑ 12.02%
Net Profit Margin	-34.7K%	↑ 22882.48%

	FY18	Y/Y Change
Profit	$-57.6M	↓ 25.08%

	FY19	Y/Y Change
Profit	$-59.3M	↑ 2.82%

	FY20	Y/Y Change
Profit	$-41.1M	↓ 30.6%

	FY21	Y/Y Change
Profit	$-89.5M	↑ 117.66%

	FY22	Y/Y Change
Profit	$-146.2M	↑ 63.36%

	FY23	Y/Y Change
Profit	$-322.6M	↑ 120.61%

	Q2 FY23	Q/Q Change
Profit	$-82.3M	↑ 10.05%

	Q3 FY23	Q/Q Change
Profit	$-82.2M	↓ 0.21%

	Q4 FY23	Q/Q Change
Profit	$-4.7M	↓ 94.32%

	Q1 FY24	Q/Q Change
Profit	$-1.5M	↓ 67.92%

	Q2 FY24	Q/Q Change
Profit	$-2.2M	↑ 44.18%

	Q3 FY24	Q/Q Change
Profit	$-84.1M	↑ 3801.21%

	FY18	Y/Y Change
Operating Cash Flow	$-101.2M	↓ 0.53%
Investing Cash Flow	$5.1M	↓ 107.8%
Financing Cash Flow	$13.1M	↓ 94.19%

	FY19	Y/Y Change
Operating Cash Flow	$-90.9M	↓ 10.18%
Investing Cash Flow	$-74.7M	↓ 1555.43%
Financing Cash Flow	$159.8M	↑ 1116.81%

	FY20	Y/Y Change
Operating Cash Flow	$8.9M	↓ 109.84%
Investing Cash Flow	$-196.5M	↑ 163.05%
Financing Cash Flow	$234.1M	↑ 46.52%

	FY21	Y/Y Change
Operating Cash Flow	$-142.5M	↓ 1693.67%
Investing Cash Flow	$-147.8M	↓ 24.8%
Financing Cash Flow	$320.0M	↑ 36.67%

	FY22	Y/Y Change
Operating Cash Flow	$-299.5M	↑ 110.15%
Investing Cash Flow	$-262.1M	↑ 77.38%
Financing Cash Flow	$516.2M	↑ 61.31%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-121.8M	↓ 0.39%
Investing Cash Flow	$82.1M	↓ 50.37%
Financing Cash Flow	$5.5M	↓ 176.29%

Cytokinetics Technicals Summary

Sell

Neutral

Buy

Cytokinetics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Cytokinetics Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Cytokinetics Inc	-2.59%	-5.41%	7.09%	6.76%	375.7%
Regeneron Pharmaceuticals, Inc.	-4.59%	-33.11%	-15.82%	12.66%	91.56%
Biontech Se	-6.0%	37.55%	8.38%	-55.46%	248.4%
Alnylam Pharmaceuticals, Inc.	-3.47%	-1.19%	26.71%	50.37%	106.11%
Vertex Pharmaceuticals Incorporated	-12.22%	-14.5%	-0.59%	82.27%	83.4%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Cytokinetics Inc	NA	NA	-0.42	-5.2	-5.72	-0.3	NA	-0.12
Regeneron Pharmaceuticals, Inc.	17.36	17.36	1.04	45.07	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.11	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.04	0.54	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Cytokinetics Inc	Buy	$5.8B	375.7%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$77.1B	91.56%	17.36	33.61%
Biontech Se	Buy	$27.1B	248.4%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$31.7B	106.11%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$102.3B	83.4%	32.84	-4.51%

Cytokinetics Dividend announcements

Cytokinetics Earnings
Cytokinetics’s price-to-earnings ratio stands at None
Read More

About Cytokinetics

cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. as a leader in muscle biology and the mechanics of muscle performance, we're developing small molecule drug candidates specifically engineered to increase muscle function and contractility.

Organization	Cytokinetics
Employees	423
CEO	Mr. Robert I. Blum
Industry	Health Technology

Management People of Cytokinetics

Name	Title
Mr. Robert I. Blum	CEO, President & Director
Mr. Robert C. Wong	VP & Chief Accounting Officer
Dr. Fady Ibraham Malik FACC, M.D., Ph.D.	Executive Vice President of Research & Development
Mr. Andrew M. Callos	Executive VP & Chief Commercial Officer
Dr. James A. Spudich Ph.D.	Co-Founder & Member of Scientific Advisory Board
Mr. Sung H. Lee	Executive VP & CFO
Mr. Jeff Lotz	Vice President of Sales & Operations
Mr. Matt Yang	Vice President of Corporate Finance and Financial Planning & Analysis
Mr. Steven M. Cook J.D.	Senior Vice President of Global Supply Chain Operations & Technical Operations
Ms. Kari K. Loeser J.D.	VP & Chief Compliance Officer

Important FAQs about investing in Cytokinetics from India :

What is Cytokinetics share price today?

Cytokinetics share price today stands at $48.53, Open: $48.85 ; Previous Close: $48.95 ; High: $49.03 ; Low: $48.07 ; 52 Week High: $110.25 ; 52 Week Low: $43.53. The stock opens at $48.85, after a previous close of $48.95. The stock reached a daily high of $49.03 and a low of $48.07, with a 52-week high of $110.25 and a 52-week low of $43.53.

Can Indians buy Cytokinetics shares?

Yes, Indians can invest in the Cytokinetics (CYTK) from India.

With INDmoney, you can buy Cytokinetics at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Cytokinetics at zero transaction cost.

How can I buy Cytokinetics shares from India?

It is very easy to buy Cytokinetics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Cytokinetics be purchased?

Yes, you can buy fractional shares of Cytokinetics with INDmoney app.

What are the documents required to start investing in Cytokinetics stocks?

To start investing in Cytokinetics, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.